JPMORGAN CHASE & CO - IONIS PHARMACEUTICALS INC ownership

IONIS PHARMACEUTICALS INC's ticker is and the CUSIP is 462222AB6. A total of 40 filers reported holding IONIS PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
JPMORGAN CHASE & CO ownership history of IONIS PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2023$25,397
-98.2%
27,000
-98.2%
0.00%
Q1 2023$1,381,000
+76156.2%
1,497,000
-24.9%
0.00%
Q4 2022$1,811
-99.9%
1,993,000
+33.3%
0.00%
Q3 2022$1,359,000
-71.1%
1,495,000
-71.3%
0.00%
-100.0%
Q1 2022$4,700,000
+413.7%
5,218,000
+422.8%
0.00%
Q3 2021$915,000998,0000.00%
Other shareholders
IONIS PHARMACEUTICALS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Opti Capital Management, LP 36,587,000$34,026,0003.65%
DeepCurrents Investment Group LLC 77,144,000$71,504,0002.14%
STEELHEAD PARTNERS LLC 28,000,000$26,028,0001.72%
Context Capital Management, LLC 13,000$12,147,0001.12%
CAMDEN ASSET MANAGEMENT L P /CA 26,324,000$24,465,0001.02%
Penn Mutual Asset Management, LLC 856$790,0000.99%
TENOR CAPITAL MANAGEMENT Co., L.P. 41,774,000$38,742,0000.84%
PFM Health Sciences, LP 23,000,000$21,372,0000.67%
AQR Arbitrage LLC 19,050,000$17,800,0000.50%
ADVENT CAPITAL MANAGEMENT /DE/ 19,910,000$18,377,0000.36%
View complete list of IONIS PHARMACEUTICALS INC shareholders